Laboratorios Farmaceuticos Rovi, S.A. (BME:ROVI)
Spain flag Spain · Delayed Price · Currency is EUR
69.60
+0.40 (0.58%)
Nov 16, 2026, 5:35 PM CET

BME:ROVI Balance Sheet

Millions EUR. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
70.9297.9827.1925.32124.9599.04
Short-Term Investments
-0.620.830.110.090.1
Cash & Short-Term Investments
70.9298.628.0225.44125.0399.14
Cash Growth
43.99%251.93%10.15%-79.66%26.13%86.22%
Accounts Receivable
247.58163.31114.83124.55160.23129.8
Other Receivables
0.1112.0412.6115.9121.0627.83
Receivables
247.69175.36127.44140.46181.28157.63
Inventory
244.59287.98329.95337.97311.94245.47
Prepaid Expenses
5.063.192.692.732.031.79
Other Current Assets
-1.591.512.742.792.33
Total Current Assets
568.25566.71489.61509.33623.07506.36
Property, Plant & Equipment
496.25330.74286.62253.65215.54181.78
Long-Term Investments
19.3119.1619.520.592.22.07
Goodwill
2.72.7----
Other Intangible Assets
32.933.1833.9527.7429.1431.51
Long-Term Deferred Tax Assets
17.383.22.262.342.083.85
Long-Term Deferred Charges
---6.166.67.05
Other Long-Term Assets
--0.070.070.070.07
Total Assets
1,137955.69832.02799.88878.7732.68

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
120.2884.7589.93109.89125.8799.4
Accrued Expenses
-30.2333.1928.8331.6724.6
Current Portion of Long-Term Debt
27.0622.2617.848.068.272.98
Current Portion of Leases
-6.365.855.134.463.44
Current Income Taxes Payable
31.764.42.385.26-0.68
Current Unearned Revenue
32.9229.645.2539.51115.3958.12
Other Current Liabilities
-3.582.213.178.231.17
Total Current Liabilities
212.02181.22156.65199.84293.89190.39
Long-Term Debt
62.7683.8880.538.5846.0452.52
Long-Term Leases
11.129.3310.2213.6713.414.22
Long-Term Unearned Revenue
30.75.462.752.793.323.79
Long-Term Deferred Tax Liabilities
21.570.160.371.520.680.78
Other Long-Term Liabilities
0.20.19----
Total Liabilities
338.38280.24250.48256.39357.32261.7

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
3.073.073.073.243.243.36
Additional Paid-In Capital
87.6487.6487.6487.6487.6487.64
Retained Earnings
692.24578.93486.89556.21456.7446.1
Treasury Stock
-5.47-5.17-5.55-107.68-27.56-66.12
Comprehensive Income & Other
2.31-0.05-0.02-0.02-0.01-0
Total Common Equity
779.79664.42572.03539.39520.01470.98
Minority Interest
18.6211.049.514.111.37-
Shareholders' Equity
798.41675.46581.54543.49521.38470.98
Total Liabilities & Equity
1,137955.69832.02799.88878.7732.68

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
100.95121.82114.4165.4372.1773.16
Net Cash (Debt)
-30.03-23.22-86.39-39.9952.8725.97
Net Cash Growth
----103.55%-
Net Cash Per Share
-0.59-0.45-1.69-0.750.990.47
Filing Date Shares Outstanding
51.1451.1551.1551.8253.3754.85
Total Common Shares Outstanding
51.1451.1551.1551.8253.3754.85
Working Capital
356.23385.49332.96309.49329.19315.97
Book Value Per Share
15.2512.9911.1810.419.748.59
Tangible Book Value
744.19628.53538.08511.65490.87439.46
Tangible Book Value Per Share
14.5512.2910.529.879.208.01
Land
-81.7974.860.6545.1237.25
Machinery
-445.19404.19372.97303.78275.44
Construction In Progress
-22.0911.018.4740.1728.06